Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

June 9, 2021

Study Completion Date

August 30, 2021

Conditions

Covid19

Interventions

BIOLOGICAL

PSC-04

adipose stem cells derived from screened donor lipoaspirate and culture expanded.

Trial Locations (1)

Fresno Community Hospital, Fresno

All Listed Sponsors

collaborator

VetStem Biopharma, Inc.

UNKNOWN

collaborator

Fresno Community Hospital and Medical Center

OTHER

lead

Sorrento Therapeutics, Inc.

INDUSTRY

NCT04486001 - Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 | Biotech Hunter | Biotech Hunter